As can be seen from the existing literature, SCARA5 is associated with conditions that include tumors, inflammation, CVD, hemophilia, retinopathy, bone lesions, connective-tissue disease, and pregnancy [10, 12, 25, 30–33]. Here, SCARA5 is linked to hemophilia.